Blunting of the Heart Rate Response to Adenosine and Regadenoson in Relation to Hyperglycemia and the Metabolic Syndrome

This publication has 18 references indexed in Scilit:

• Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus
  American Heart Journal, 2009
• Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
  Neurobiology of Disease, 2008
• Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging
  JACC: Cardiovascular Imaging, 2008
• Impaired Glucose Tolerance and Neuropathy
  The Neurologist, 2008
• Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial
  Journal of Nuclear Cardiology, 2007
• Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy
  Diabetes Care, 2006
• Tachycardia Caused by A2A Adenosine Receptor Agonists Is Mediated by Direct Sympathoexcitation in Awake Rats
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Diagnosis and Management of the Metabolic Syndrome
  Circulation, 2005
• The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With Diabetes
  Diabetes Care, 2003
• Mechanism and Pressor Relevance of the Short-Term Cardiovascular and Renin Excitatory Actions of the Selective A2A-Adenosine Receptor Agonists
  Journal of Cardiovascular Pharmacology, 1997